Peninsula biotech files for Chapter 11 bankruptcy protection

The company in late 2020 sold a so-called priority review voucher for $95 million, but it had less than $40 million banked by the end of September 2023.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 2, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news